Naltrindole derivatives with fluorinated ethyl substituents on the 17-nitrogen as δ opioid receptor inverse agonists

Bioorg Med Chem Lett. 2015 Aug 1;25(15):2927-30. doi: 10.1016/j.bmcl.2015.05.038. Epub 2015 May 22.

Abstract

We synthesized derivatives of the δ opioid receptor (DOR) antagonists naltrindole (NTI) and compound 1 that were modified with small alkyl or fluorinated ethyl substituents on the 17-nitrogen. Although the derivatives showed decreased binding affinities for the opioid receptors, their selectivities for the DOR were higher than the parent compounds NTI and compound 1. Surprisingly, 17-fluoroethyl NTI derivatives exerted DOR inverse agonistic activities. The DOR inverse agonism of compounds 4c-e was less efficacious but significant, as compared with a standard DOR inverse agonist ICI-174864. On the other hand, compound 1 and its derivatives with small alkyl or monofluoroethyl substituents were partial agonists, but the derivatives having di- or trifluoroethyl group showed neither agonistic nor inverse agonistic activities.

Keywords: Fluoroalkyl substituent; Inverse agonist; NTI derivative; δ opioid receptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Drug Inverse Agonism
  • Enkephalin, Leucine / analogs & derivatives
  • Enkephalin, Leucine / pharmacology
  • Halogenation
  • Humans
  • Naltrexone / analogs & derivatives*
  • Naltrexone / chemistry
  • Naltrexone / pharmacology
  • Narcotic Antagonists / chemistry*
  • Narcotic Antagonists / pharmacology*
  • Receptors, Opioid, delta / agonists*
  • Receptors, Opioid, delta / metabolism
  • Recombinant Proteins / metabolism

Substances

  • Narcotic Antagonists
  • Receptors, Opioid, delta
  • Recombinant Proteins
  • Enkephalin, Leucine
  • Naltrexone
  • N,N-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine
  • naltrindole